RIVERVIEW, FL
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)FLORIDA SOCIETY OF CLINICAL ONCOLOGY INC, founded in 1977, is a community nonprofit in the Diseases & Disorders sector that reported $2.8M in total revenue in fiscal year 2023. Revenue grew 11% year-over-year, indicating healthy expansion. The organization ran a surplus of $768K, a strong 27% operating margin.
THE FLORIDA SOCIETY OF CLINICAL ONCOLOGY IS A STATEWIDE NON-PROFIT ORGANIZATION COMMITTED TO FACILITATING AND PROMOTING MULTIDISCIPLINARY EFFORTS TO IMPROVE PATIENT CARE IN FLORIDA BY:- FOSTERING ACCESS TO QUALITY CANCER CARE TO THE CITIZENS OF FLORIDA.- ASSISTING THE CANCER PRACTITIONERS IN PROVIDING THE MOST COST EFFECTIVE QUALITY CARE FOR THEIR PATIENTS.- ACTING AS AN ADVOCATE FOR FLORIDA CANCER PATIENTS AND THEIR FAMILIES.- COORDINATING THE DISSEMINATION OF INFORMATION AND PROVIDING AN OPPORTUNITY FOR ONCOLOGISTS, PHYSICIANS, AND OTHER HEALTH CARE PROFESSIONALS TO NETWORK AND EXCHANGE INFORMATION.
EDUCATIONFLASCO PROVIDES SEVEN EDUCATIONAL SESSIONS ANNUALLY FOR ITS MEMBERS COVERING SCIENTIFIC AND BUSINESS OF ONCOLOGY TOPICS. IN ADDITION, EACH YEAR FLASCO HOLDS A BUSINESS OF ONCOLOGY SUMMIT FOR...
EDUCATIONFLASCO PROVIDES SEVEN EDUCATIONAL SESSIONS ANNUALLY FOR ITS MEMBERS COVERING SCIENTIFIC AND BUSINESS OF ONCOLOGY TOPICS. IN ADDITION, EACH YEAR FLASCO HOLDS A BUSINESS OF ONCOLOGY SUMMIT FOR ITS MEMBERS.FLASCO SPONSORS AN ASCO YOUNG INVESTIGATOR'S AWARD FOR FLORIDA FELLOWS AND IS CURRENTLY SUPPORTING EDUCATIONAL GRANTS TO FACILITATE FELLOW TRAVEL TO NINE DIFFERENT ONCOLOGY CONFERENCES. THESE GRANT OPPORTUNITIES FACILITATE COLLABORATION, LEARNING, AND PROFESSIONAL NETWORKING AND PROVIDE FELLOWS THE OPPORTUNITY TO EXPAND THEIR TRAINING BY PARTICIPATING IN THESE MEETING AND BECOMING INVOLVED IN THE SOCIETIES OF PEER PROFESSIONALS.OPPORTUNITIES FOR ACTIVE PARTICIPATION IN AND LEARNING ABOUT THE ADMINISTRATIVE ASPECTS OF CLINICAL CARE THROUGH FLASCO MEMBER MENTORSHIP AND COMMITTEE INVOLVEMENT ARE ENCOURAGED.EMPLOYMENT OPPORTUNITIES IN FLORIDA AFTER FELLOWSHIP CAN BE FACILITATED THROUGH FLASCO MEMBERS AND ADMINISTRATION. JUNIOR FACULTY AND RECENT GRADUATES ARE ENCOURAGED TO TAKE ADVANTAGE OF THESE RESOURCES, PARTICULARLY THE MENTORSHIP, EDUCATIONAL AND ADMINISTRATIVE ASPECTS OF PROFESSIONAL DEVELOPMENT THROUGH FLASCO.FLASCO FELLOW MEMBERSHIP AND ASSOCIATED BENEFITS ARE FREE TO ANY TRAINEE OF A FLORIDA HEMATOLOGY OR MEDICAL ONCOLOGY FELLOWSHIP PROGRAM.PROVIDED 10 EDUCATIONAL EVENTS FOR CANCER PATIENTS AND THEIR CAREGIVERS, PROVIDING INFORMATION ABOUT THEIR DISEASE, TREATMENT OPTIONS, FINANCIAL SUPPORT, AND THE IMPORTANCE OF A CAREGIVER. PROVIDE TWO EDUCATIONAL MEETINGS EACH YEAR SPECIFICALLY FOR NURSES, NURSE PRACTITIONERS, ANDPHYSICIAN ASSISTANTS, WHICH HAVE BEEN VERY WELL RECEIVED AND DRAW OVER 150 ONCOLOGY HEALTHCARE PROVIDERS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $2,803,382 | $2,531,361 | +0.1% |
| Expenses | $2,035,165 | $1,889,962 | +0.1% |
| Net Income | $768,217 | $641,399 | +0.2% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| LUIS RAEZ MD | PAST PRESIDENT | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| WINSTON TAN MD | PRESIDENT | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| MAEN HUSSEIN MD | VICE PRESIDENT | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| EDGARDO SANTOS CASTILLERO MD FACP | TREASURER | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| DINA DUMERCY PHARMD BCOP BCPS | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| ARDESHIR HAKAM MD MBA | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| KUN JIANG MD PHD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| RESHMA MAHTANI DO | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JOSEPH MIGNONE MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| ANAY MOSCU PHARMD BCPS BCOP | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| BRENDAN PRENDERGAST MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JOSEPH ROSENBLATT MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JOSE SANDOVAL-SUS MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JASON STARR DO | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| BARRY BERMAN MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| CHAKRA CHAULAGAIN MD FACP | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| LAURA FREEDMAN MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| FAITHLORE GARDNER MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| ERIC HARRIS DO | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MEHDI MOEZI MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| ZEINA NAHLEH MD FACP | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| PARESHKUMAR PATEL MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| SIKANDER ALLAWADHI MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| STEVEN FEIN MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JORGE GARCIA PHARMD MHA FACHE | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| THOMAS GEORGE MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| NALINI HASIJA MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MOHAMMAD JAHANZEB MD FACP | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| LORETTA LOFTUS MD MBA | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| YAN MAKEYEV MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| OMAR RASHID MD JDS FACS | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| SCOTT TETREAULT MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MAGALI VAN DEN BERGH MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JONATHAN ZAGER MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MANMEET AHULWALIA MD MBA | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| RAMI MANOCHAKIAN MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| MERRY JENNIFER MARKHAM MD FACP | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| NATHALIE MCKENZIE MD MSPH FACOG | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| ASHWIN MEHTA MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| CESAR PEREZ MD | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| EDUARDO SOTOMAYOR DO | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JULIE NEWBERRY | EXECUTIVE DIRECTOR | 40.00 |
Officer
|
$174,381 | $0 | $174,381 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $2,803,382 | $2,035,165 | $4,546,560 | $768,217 |
| 2022 | $2,531,361 | $1,889,962 | $3,573,540 | $641,399 |
| 2021 | $1,540,570 | $1,217,037 | $3,143,681 | $323,533 |
| 2020 | $1,381,574 | $937,392 | $2,808,290 | $444,182 |
| 2019 | $1,332,814 | $1,118,858 | $2,363,098 | $213,956 |
| 2018 | $1,237,210 | $963,696 | $2,111,765 | $273,514 |
Compare FLORIDA SOCIETY OF CLINICAL ONCOLOGY INC with other nonprofits in Florida and across the country.